Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-22

FDA Approved: FUROSCIX — Supplemental Application (scPharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for FUROSCIX (furosemide injection 80 mg/10 mL) from scPharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FUROSCIX (Furosemide injection 80 mg/10 mL)

Snippet

SUPPL AP for FUROSCIX (FUROSEMIDE INJECTION 80 MG/ 10 ML)